Oceanic Iron Ore Corp. (FEOVF)

Elevation Oncology Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of Revenue	-	-	-	0.03	0.03	0.03
Gross Profit	-	-	-	-0.03	-0.03	-0.03
Selling, General & Admin	0.54	0.5	0.43	0.48	0.46	0.42
Operating Expenses	0.74	0.67	0.54	0.53	0.57	0.73
Operating Income	-0.74	-0.67	-0.54	-0.56	-0.6	-0.76
Interest Expense	-0.8	-0.7	-0.54	-0.45	-0.36	-0.23
Other Non Operating Income (Expenses)	-9.08	-3.31	1.13	-0.05	4.05	-3.59
Pretax Income	-10.62	-4.68	0.05	-1.06	3.1	-4.58
Net Income	-10.62	-4.68	0.05	-1.06	3.1	-4.58
Net Income to Common	-10.62	-4.68	0.05	-1.06	3.1	-4.58
Shares Outstanding (Basic)	112	110	103	97	94	93
Shares Outstanding (Diluted)	112	110	103	97	128	93
Shares Change (YoY)	6.56%	6.67%	6.31%	-23.92%	37.64%	31.77%
EPS (Basic)	-0.09	-0.04	0.00	-0.01	0.03	-0.05
EPS (Diluted)	-0.09	-0.04	0.00	-0.01	0.02	-0.05
Free Cash Flow	-1.1	-1.05	-0.32	-0.68	-0.93	-0.24
Free Cash Flow Per Share	-0.01	-0.01	-0.00	-0.01	-0.01	-0.00
EBIT	-0.74	-0.67	-0.54	-0.56	-0.6	-0.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.